AbbVie Inc. / Headquarters

0

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C.

It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants.

AbbVie Inc. Headquarters
AbbVie Inc. logo

AbbVie Inc. researches and develops pharmaceutical products.

Address: 1 North Waukegan Road North Chicago, IL 60064 United States
Phone Number: 1-847-932-7900
Website: www.abbvie.com

Company Overview of AbbVie Inc.

Traded as NYSE: ABBV
Industry Biopharmaceutical
Founded 2013; 6 years ago
Headquarters Lake Bluff, Illinois, United States
Area served Worldwide
Key people Richard A. Gonzalez (Chairman & CEO)

Products Pharmaceutical drugs

  • Humira (adalimumab)
  • Imbruvica (ibrutinib)
  • Venclexta (venetoclax)
  • Zinbryta (daclizumab)
  • Kaletra (lopinavir)
  • Norvir (ritonavir)
  • Mavyret/Maviret (glecaprevir/pibrentasvir)

Where is AbbVie located?

Pharmaceutical Contract Manufacturing Locations in United States (USA), Ireland, Germany, Italy, Puerto Rico – AbbVie Contract Manufacturing.